Search results
Gordana Vunjak-Novakovic Granted Chan Zuckerberg Biohub New York Investigator Award to Advance...
Columbia University News· 5 days agoGordana Vunjak-Novakovic, a bioengineer renowned for her pathbreaking work in engineering functional...
Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
Journal of the American Medical Association· 5 days agoThis cohort study examines whether a watchful waiting treatment strategy is associated with adverse outcomes in men with nonmetastatic prostate cancer and a life expectancy of less than 10 years in Sweden.
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 7 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Aptevo Participating in the BIO International Convention
Digital Journal· 6 days ago...mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection More...
Immunotherapy before surgery very successful in treating colorectal cancer, trial finds
Medical Xpress· 3 days agoPatients with colon cancer with a specific genetic makeup, known as mismatch-repair deficient (dMMR) or microsatellite instable (MSI), were treated with one cycle of ipilimumab and two cycles ...
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 6 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer that was surgically removed. With ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 SUZHOU, China ...
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side...
Valley City Times Record· 7 days agoThe PRIMED study found a way to reduce treatment-related side effects among participants, decreasing...
A Bird’s Eye View of the Tumor Microenvironment
The Scientist· 6 days agoThe tumor microenvironment is a battleground where infiltrating immune cells either subdue or promote a cancer, all while cancer cells try to dampen the body’s defenses.1,2 Scientists have studied ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoResearchers from NYU Langone Health's Perlmutter Cancer Center are presenting their latest findings and research at the 2024 American Society of Clinical Oncology (ASCO) Annual Conference, held ...
